SEASPINE HOLDINGS CORP (SPNE) Stock Price, Forecast & Analysis
NASDAQ:SPNE • US81255T1088
SPNE Key Statistics, Chart & Performance
The current stock price of SPNE is 9.54 USD. In the past month the price increased by 24.38%. In the past year, price decreased by -24.58%.
SPNE Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to SPNE. When comparing the yearly performance of all stocks, SPNE is one of the better performing stocks in the market, outperforming 92.08% of all stocks.
SPNE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SPNE. The financial health of SPNE is average, but there are quite some concerns on its profitability.
SPNE Financial Highlights
Over the last trailing twelve months SPNE reported a non-GAAP Earnings per Share(EPS) of -1.77. The EPS decreased by -20.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.09 |
SPNE Forecast & Estimates
14 analysts have analysed SPNE and the average price target is 16.13 USD. This implies a price increase of 69.06% is expected in the next year compared to the current price of 9.54.
For the next year, analysts expect an EPS growth of -1.82% and a revenue growth 24.57% for SPNE
SPNE Ownership
SPNE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.55 | 195.206B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.27 | 175.203B | ||
| SYK | STRYKER CORP | 24.42 | 141.182B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 113.14B | ||
| BDX | BECTON DICKINSON AND CO | 11.26 | 50.537B | ||
| IDXX | IDEXX LABORATORIES INC | 42.26 | 50B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.39 | 45.525B | ||
| RMD | RESMED INC | 20.83 | 37.268B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.25 | 37.194B | ||
| DXCM | DEXCOM INC | 27.89 | 27.469B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SPNE
Company Profile
SeaSpine Holdings Corp. operates as a medical technology company. The company is headquartered in Carlsbad, California and currently employs 523 full-time employees. The company went IPO on 2015-06-17. The firm is focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company offers a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products consist of a range of advanced and traditional bone graft substitutes designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip, and extremities procedures. The firm's spinal implants and enabling technologies portfolio consists of a line of products and image-guided surgical solutions to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures.
Company Info
SEASPINE HOLDINGS CORP
5770 Armada Dr
Carlsbad CALIFORNIA 92008 US
CEO: Keith C. Valentine
Employees: 523
Phone: 17607278399.0
SEASPINE HOLDINGS CORP / SPNE FAQ
What does SPNE do?
SeaSpine Holdings Corp. operates as a medical technology company. The company is headquartered in Carlsbad, California and currently employs 523 full-time employees. The company went IPO on 2015-06-17. The firm is focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company offers a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products consist of a range of advanced and traditional bone graft substitutes designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip, and extremities procedures. The firm's spinal implants and enabling technologies portfolio consists of a line of products and image-guided surgical solutions to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures.
Can you provide the latest stock price for SEASPINE HOLDINGS CORP?
The current stock price of SPNE is 9.54 USD. The price increased by 8.29% in the last trading session.
Does SPNE stock pay dividends?
SPNE does not pay a dividend.
What is the ChartMill rating of SEASPINE HOLDINGS CORP stock?
SPNE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of SEASPINE HOLDINGS CORP (SPNE) based on its PE ratio?
SEASPINE HOLDINGS CORP (SPNE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.77).
Would investing in SEASPINE HOLDINGS CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SPNE.
What is the expected growth for SPNE stock?
The Revenue of SEASPINE HOLDINGS CORP (SPNE) is expected to grow by 24.57% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.